Glass Drug Chamber For Automated Ophthalmic Injection Device

• US 20090177182A1
• Filed: 01/09/2008
• Published: 07/09/2009
• Est. Priority Date: 01/09/2008
• Status: Abandoned Application

• Current Assignee: Alcon Research Limited (Nestle SA)
• Original Assignee: Alcon Manufacturing Limited (Alcon Incorporated)
• Inventors: Sanchez, Robert J. JR., Hickingbotham, Dyson W.
• Application Number:
  US11/971,443
• Publication Number:
  US 20090177182A1
• Time in Patent Office: Days
• US Class Current: 604/506
• CPC Class Codes: A61F 9/0017 implantable in, or in contact with, the eye, e.g. ocular inserts
• CPC Class Codes: A61M 5/44 having means for cooling or heating the devices or media

Abstract

A dispensing assembly has a glass tube assembly, a chamber housing, a needle, and a temperature control device. The glass tube assembly includes a glass tube with inner and outer surfaces and distal and proximal ends. A plunger is fluidly sealed to the inner surface of the glass tube at the proximal end, and a seal is located at the distal end of the glass tube. The chamber housing has an inner surface and an outer surface. The inner surface partially defines a chamber for receiving the glass tube assembly. The needle has sharp distal and proximal ends, traverses the chamber housing, and is fluidly coupled to the chamber. The temperature control device at least partially surrounds the chamber housing. The proximal end of the needle is arranged to puncture the seal when the glass tube assembly is pressed against the proximal end of the needle.

Claims

1. A dispensing assembly comprising:

a glass tube assembly comprising a glass tube having inner and outer surfaces and distal and proximal ends, a plunger fluidly sealed to the inner surface of the glass tube at the proximal end, and a seal located at the distal end of the glass tube;

a chamber housing having an inner surface and an outer surface, the inner surface partially defining a chamber for receiving the glass tube assembly;

a needle having sharp distal and proximal ends, the needle traversing the chamber housing and fluidly coupled to the chamber;

a temperature control device at least partially surrounding the chamber housing;

wherein the proximal end of the needle is arranged to puncture the seal when the glass tube assembly is pressed against the proximal end of the needle.

2. The assembly of claim 1 wherein the seal is made of a self-sealing elastomer.

3. The assembly of claim 1 wherein the glass tube contains a drug suspended in a phase transition compound.

5. The assembly of claim 1 further comprising:

a housing at least partially enclosing the chamber housing.

6. The assembly of claim 1 further comprising:

a thermal sensor in thermal contact with the chamber housing.

7. The assembly of claim 1 further comprising:

an actuator having a shaft; and

a mechanical linkage interface for engaging the plunger.

8. The assembly of claim 7 wherein the mechanical linkage interface is arranged to contact the plunger and press the seal against the proximal end of the needle to puncture the seal.

10. The assembly of claim 1 wherein the seal is made of a self-sealing elastomer.

11. The assembly of claim 1 further comprising:

a housing at least partially enclosing the chamber housing.

12. The assembly of claim 1 further comprising:

a thermal sensor in thermal contact with the chamber housing.

4. The assembly of claim 4 wherein the temperature control device is a heater for heating the drug suspended in the phase transition compound.

9. A dispensing assembly comprising:

a glass tube assembly comprising a glass tube having inner and outer surfaces and distal and proximal ends, a plunger fluidly sealed to the inner surface of the glass tube at the proximal end, and a seal located at the distal end of the glass tube, the glass tube containing a drug suspended in a phase transition compound;

a chamber housing having an inner surface and an outer surface, the inner surface partially defining a chamber for receiving the glass tube assembly;

a needle having sharp distal and proximal ends, the needle traversing the chamber housing and fluidly coupled to the chamber;

a heater at least partially surrounding the chamber housing, the heater for heating the drug and phase transition compound;

wherein the proximal end of the needle is arranged to puncture the seal when the glass tube assembly is pressed against the proximal end of the needle.

13. A method of injecting a drug suspended in a phase transition compound into an eye, the method comprising:

providing a glass tube assembly comprising a glass tube having inner and outer surfaces and distal and proximal ends, a plunger fluidly sealed to the inner surface of the glass tube at the proximal end, and a seal located at the distal end of the glass tube, the glass tube containing a drug suspended in a phase transition compound;

heating the glass tube assembly after it is located in a chamber housing having an inner surface and an outer surface, the inner surface partially defining a chamber for receiving the glass tube assembly;

puncturing the seal with a needle having sharp distal and proximal ends, the needle located in the chamber housing and fluidly coupled to the chamber; and

dispensing the drug suspended in the phase transition compound by moving the plunger toward the needle.

14. The method of claim 13 further comprising:

providing an interface between a tip segment containing the chamber housing and a limited reuse assembly.

15. The method of claim 13 wherein puncturing the seal with a needle having sharp distal and proximal ends further comprises providing force on the plunger to drive the seal into the proximal end of the needle.

16. The method of claim 13 wherein puncturing the seal with a needle having sharp distal and proximal ends further comprises providing force on the plunger to drive the seal into the proximal end of the needle after the drug suspended in the phase transition compound has been heated.